Cardiac Rhythm Management
banner AtriCure converge2018

 

Activity Description

This enduring educational activity reviews existing practice gaps with traditional Atrial Fibrillation treatment strategies, and examines the structural mechanistic basis of Persistent Atrial Fibrillation, and clinical evidence supporting Hybrid Endocardial/Epicardial Ablation and Posterior Wall Isolation. The leading experts also evaluate the rationale and design of the CONVERGE and DEEP Trials.

This activity was created from the live proceedings of a satellite symposium held at Heart Rhythm 2018.

Cardiac Rhythm Management

Access Presentation

Webcast

Click on the session title listed below to view each presentation.

For those wishing to obtain your continuing medical education certification, access Earn CME Credit Tab at the conclusion of the webcast; select the appropriate answer to each posttest question, and successfully obtain the passing score as designated at the top of the test.

tmb webcast AtriCureHRS2018 K Makati pres

Insights into the Structural and Mechanistic Basis of Persistent Atrial Fibrillation: Arguments Supporting Hybrid Endocardial/Epicardial Ablation and Posterior Wall Isolation.
Kevin Makati, MD, FACC, FHRS

play-webcast

tmb webcast AtriCureHRS2018 D Delurgio pres

Convergence of Epicardial and Endocardial RF Ablation for the Treatment of Symptomatic Persistent AF
David DeLurgio, MD, FACC, FHRS

play-webcast

tmb webcast AtriCureHRS2018 K Ellenborgen pres

DEEP Trial: Hybrid Ablation
Kenneth Ellenbogen, MD

play-webcast

tmb webcast AtriCureHRS2018 panel

Panel Discussion
Panel: David DeLurgio, MD, FACC, FHRS, Kenneth Ellenbogen, MD, Kevin Makati, MD, FACC, FHRS

play-webcast

Cardiac Rhythm Management

Commercial Supporter

This activity is supported by an educational grant from AtriCure

Joint-Providers

MediaSphere Medical, LLC and Ciné-Med

 

Faculty

Faculty

tmb webcast AtriCureHRS2018 D Delurgio port

David DeLurgio, MD, FACC, FHRS
Professor of Medicine
Division of Cardiology, Department of Medicine
Emory University School of Medicine
Atlanta, GA

tmb webcast AtriCureHRS2018 K Ellenborgen port

Kenneth Ellenbogen, MD
Martha M. and Harold W. Kimmerling Professor of Cardiology
Chair, Cardiology
VCU School of Medicine
Richmond, VA

tmb webcast AtriCureHRS2018 K Makati port

Kevin Makati, MD, FACC, FHRS
Rhythm Section Chairperson, Baycare Health Systems
Co-Director Arrhythmia Department, St. Joseph’s Hospital
Tampa, FL

 

CME Information

CME Released: 5/31/2018; Valid for credit through 5/31/2019

Target Audience

This enduring activity has been developed to meet the educational needs of electrophysiologists, cardiologists, surgeons, and other physicians and associated professionals who are dedicated to managing patients with atrial fibrillation.

Activity Goal

This activity is designed to address the following ABMS/IOM competencies: Patient Care, Medical Knowledge, and Practice-Based Learning.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Review structural and mechanistic basis of Persistent Atrial Fibrillation, and clinical evidence supporting Hybrid Endocardial/Epicardial Ablation and Posterior Wall Isolation.
  • Evaluate the rationale and design of the CONVEREGE Trial for the treatment of Symptomatic Persistent Atrial Fibrillation.
  • Examine the rationale and design of the DEEP Trial for the treatment of subjects with Persistent or Longstanding Persistent Atrial Fibrillation.

Accreditation Statement

Jointly Accredited Provider TMIn support of improving patient care, this activity has been planned and implemented by Ciné-Med and MediaSphere Medical. Ciné-Med is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Ciné-Med designates this enduring activity for a maximum of 1.5 AMA PRA Category 1Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity provides 1.50 contact hours for nurses.

Disclosure

MediaSphere Medical and Ciné-Med adheres to accreditation requirements regarding industry support of continuing medical education. Disclosure of the planning committee and faculty's commercial relationships will be made known at the activity. Speakers are required to openly disclose any limitations of data and/or any discussion of any off-label, experimental, or investigational uses of drugs or devices in their presentations. All Ciné-Med and MediaSphere Medical employees and planners in control of content have indicated that they have no relevant financial relationships to disclose.

Faculty Disclosure Summary

David DeLurgio discloses that he has received research support from AtriCure, and is a member of the speaker’s bureau for AtriCure. 

Kenneth Ellenbogen has disclosed that he receives speaker honoraria and research grants from AtriCure.

Kevin Makati discloses  that he has received financial support from AtriCure, Boston Scientific, Medtronic, and Abbott

Non Endorsement Statement

MediaSphere Medical and Cine-Med verifies that sound education principles have been demonstrated in the development of this educational offering as evidenced by the review of its objectives, teaching plan, faculty, and activity evaluation process. MediaSphere Medical and Cine-Med does not endorse or support the actual opinions or material content as presented by the speaker(s) and/or sponsoring organization.

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. This activity is designed to be completed within the time designated on the title page; physicians and nurses should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™ or Contact Hours, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and faculty disclosures.
  2. Review the educational presentations
  3. Select the appropriate answer to each posttest question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

Provider Contact Information

For technical support or CME/CE questions regarding this activity, please email us at This e-mail address is being protected from spambots. You need JavaScript enabled to view it .

Hardware/Software Requirements:

  • A computer with an Internet connection.
  • Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser.
  • Adobe Flash Player and/or an HTML5 capable browser may be required for video or audio playback.
  • Occasionally other additional software may be required such as PowerPoint or Adobe Acrobat Reader.

MediaSphere protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. MediaSphere and our joint sponsors will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency. MediaSphere maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2018 by MediaSphere Medical. All rights reserved. No part of this activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from MediaSphere Medical

 

CME/CE Test

CME/CE Test
  1. Achieving Optimal Outcomes for Persistent Atrial Fibrillation Patients through Hybrid Ablation
  2. Please enter your information, and complete the following CME post test and evaluation form. Upon successful completion, your submission will be reviewed and you will receive notification shortly regarding the status of your certificate. You must achieve a minimum score of 70% to earn credit for this activity.

  3. First Name: *  
    Invalid Input
  4. Last Name: *  
    Invalid Input
  5. Primary Email Address: *  
    Invalid Input
  6. Confirm Your Email: *  
    Invalid Input
  7. Degree: *  
    Invalid Input
  8. Institution: *  
    Invalid Input
  9. Mailing Address:*  
    Invalid Input
  10. City: *  
    Invalid Input
  11. State: *  
    Invalid Input

  12. 1. The posterior wall has been shown to harbor AF triggers, and proves to be a viable ablation target.
  13. Select one*  


    Invalid Input Please Select one

  14. 2. Ablation of the posterior wall decreases AF beyond PVI.
  15. Select one*  


    Invalid Input Please Select one

  16. 3. The study purpose of the CONVERGE IDE Clinical Trial is to evaluate the safety and efficacy of the Epi-Sense® - AF Guided Coagulation System with VisiTrax® for the treatment of symptomatic persistent Atrial Fibrillation (AF) patients refractory or intolerant to at least one Class I and/or Class III anti-arrhythmic drug (AAD).
  17. Select one*  


    Invalid Input Please Select one

  18. 4. The objective of the DEEP Pivotal Trial is to establish the safety and effectiveness of a dual epicardial and endocardial ablation procedure for patients presenting with Persistent AF or Longstanding AF.
  19. Select one*  


    Invalid Input Please Select one

  20. 5. The primary effectiveness endpoint of the DEEP Trial is freedom from any documented AF, atrial flutter, or atrial tachycardia lasting >30 seconds in duration through the 12 month follow-up visit in the absence of Class I or III AADs (with exception of previously failed AADs at doses not exceeding those previously failed.
  21. Select one*  


    Invalid Input Please Select one

  22. 6. Atrio-esophageal fistula (AEF) is a rare complication which can occur in any procedure that involves ablation near the posterior wall of the left atrium.
  23. Select one*  


    Invalid Input Please Select one

  24. 7. Which risk mitigating actions proposed to the FDA to reduce the risk of AEF is accurate?
  25. Select one*  






    Invalid Input Please Select one

  26. Although optional, we respectfully request that you complete the activity evaluation form, since your feedback assists in the development of future educational activities.

  27. Background

    Please rate each question using a scale of 1 to 5 (1 = Beginner, 5 = Advanced)


  28. I would consider my level of expertise in the subject matter prior to the webcast as:
    Invalid Input Please Select one

  29. I would consider my level of expertise in the subject matter after the activity
    Invalid Input

  30. Considering my experience and background, the material presented was:
    Invalid Input Please Select one

  31. Extent to which activity met the identified objectives
    Please rate each question using a scale of 1 to 5 (1 = Not Met, 5 = Completely Met)

  32. Review structural and mechanistic basis of Persistent Atrial Fibrillation, and clinical evidence supporting Hybrid Endocardial/Epicardial Ablation and Posterior Wall Isolation.
    Invalid Input Please Select one

  33. Evaluate the rationale and design of the CONVEREGE Trial for the treatment of Symptomatic Persistent Atrial Fibrillation.
    Invalid Input Please Select one

  34. Examine the rationale and design of the DEEP Trial for the treatment of subjects with Persistent or Longstanding Persistent Atrial Fibrillation.
    Invalid Input Please Select one

  35. Information Presented
    Please evaluate the information that was presented by answering Yes, No, Maybe or Not Applicable

  36. Reinforced my current practice/treatment habits:
    Invalid Input Please Select one

  37. Will improve my practice/patient outcomes:
    Invalid Input Please Select one

  38. Enhanced my current knowledge base:
    Invalid Input Please Select one

  39. Provided new ideas or information that I expect to use:
    Invalid Input Please Select one

  40. Information gained from this conference will result in making a change in your practice:
    Invalid Input Please Select one

  41. Future activities on this subject matter is important to my practice:
    Invalid Input Please Select one

  42. Addressed a professional practice gap:
    Invalid Input Please Select one

  43. Was free of commercial bias/influence:
    Invalid Input Please Select one

  44. What barriers do you anticipate in incorporating best practices learned in this activity into clinical activities or quality improvement initiatives at your institution?
    Invalid Input

  45. What mechanisms can you identify to overcome these barriers?
    Invalid Input

  46. (*) Required Fields
  47. Invalid Input

Cardiac Rhythm Management